https://www.news-medical.net/news/20220826/New-advice-aims-to-reduce-the-cardiac-side-effects-of-cancer-treatment.aspx
Even with the above latest advice re: cardiac side effects and Dexrazoxane. Every day, Oncologists around world is struggling to make a painful decision whether to continue treatment or stop therapy that highly likely to cure cancer BUT later on kill patient with heart failure.
Hopefully Zantrene would make his job Dr Lyon easier one day.Best of both worlds as Dr Tillett said:"Enhanced anti-cancer efficacy and Cardioprotection." The holy Grail.
Ann: Appendix 4E & Annual Report, page-28
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
0.040(2.35%) |
Mkt cap ! $295.4M | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.82 | $1.72 | $182.5K | 104.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1977 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 111 | 2 |
View Market Depth
| Last trade - 12.57pm 08/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |